文献速递中医内科中药与中成药合理使用

中药治疗重症肌无力:系统评价与Meta分析

Chinese Herbal Medicine for Myasthenia Gravis: A Systematic Review and Meta-Analysis.
PubMed 文献 · Front Pharmacol · 2018-08-30

结果显示中药辅助治疗在提高疗效方面优于单用西药或安慰剂(p < 0.01),不良反应和复发率较少,可能机制与调节Tregs功能重建免疫调节有关。但方法学缺陷和中药异质性限制了证据强度。

要点

  • 中药辅助治疗重症肌无力可能提高疗效,优于单用西药或安慰剂(p < 0.01)。
  • 中药组不良反应和总复发率较对照组少。
  • 可能机制与恢复Tregs功能重建免疫调节相关。

核心结论

  • 中药作为辅助治疗对重症肌无力可能有效且安全性较好,但方法学缺陷和中药异质性使证据强度有限,需进一步严格RCT验证。

研究设计与样本

  • 采用Cochrane协作网7项标准评估方法学质量,选择≥4个领域为「是」的研究进行详细评估和Meta分析,使用RevMan 5.3软件分析。

主要发现

  • Meta分析显示中药辅助治疗在提高疗效方面显著优于单用西药或安慰剂(p < 0.01)。
  • 与对照组相比,中药组不良反应和总复发率较少。
  • 中药治疗重症肌无力的可能机制与恢复Tregs功能能力重建免疫调节有关。

临床怎么用

  • 中药可作为重症肌无力的辅助治疗选择,但需结合患者具体情况并关注中药异质性。

局限性

  • 纳入研究方法学存在缺陷,且中药存在异质性,证据强度有限。
  • 需要进一步开展严格设计的随机对照试验验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Myasthenia gravis (MG) is an acquired autoimmune disease with the disorder of the neuromuscular junction transmission caused by autoantibodies. Currently, various Chinese herbal medicines (CHMs) are widely used for MG. This meta-analysis was conducted to assess the effectiveness and safety of CHMs for MG and its possible mechanisms. Fourteen studies with 1039 individuals were identified by searching seven databases from inception to March 2017. The methodological quality was assessed by using 7-item criteria from the Cochrane's Collaboration tool, and which assessed ≥4 "yes" in the domains were selected for detailed assessment and meta-analysis. All the data were analyzed using Rev-Man 5.3 software. Meta-analysis showed a significant effect of CHM as adjuvant therapy for improving the effectiveness compared with WCM alone or placebo in treating MG (p < 0.01). Moreover, there were fewer adverse effects and relapse rate in total when compared with the control group. The possible mechanisms of CHM for MG are associated with immunoregulation by reconstituting the functional ability of Tregs. In conclusion, despite the apparent positive results, the present evidence supports, to an extent, that CHM can be used for MG patients because of the methodological flaws and CHM heterogeneity. Further rigorous RCT for MG is needed.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Chen S, Xu MB, Zhou XL, et al. Chinese Herbal Medicine for Myasthenia Gravis: A Systematic Review and Meta-Analysis. Front Pharmacol. 2018. PMID: 30214409. doi:10.3389/fphar.2018.00969

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。